Clinical trial
Safety, Immunological Effect and Efficacy of the Combined Application of MPL and…
NCT00241410 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00241410 |
|---|---|
| Title | Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen |
| Official title | Investigation of the Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | OralvacB2MPL |
| Enrollment | 86 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Oct 19, 2005 |
| Last update posted | Jun 17, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: